{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:04:56Z","timestamp":1786993496295,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","award":["15\/180\/55"],"award-info":[{"award-number":["15\/180\/55"]}],"id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jtcvs.2025.09.040","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T15:39:18Z","timestamp":1759419558000},"page":"649-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Propofol-supplemented cardioplegia: A multicenter blinded 3-group randomized trial (Propofol for Myocardial Protection Trial 2: ProMPT2)"],"prefix":"10.1016","volume":"171","author":[{"given":"Gianni D.","family":"Angelini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena J.M.","family":"Smartt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Heys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Maishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Culliford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha E.","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth M.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Saadeh","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Punjabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnamdi","family":"Nwaejike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Gibbison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris A.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtcvs.2025.09.040_bib1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0008-6363(99)00365-X","article-title":"Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition","volume":"45","author":"Javadov","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"24","key":"10.1016\/j.jtcvs.2025.09.040_bib2","first-page":"11051","article-title":"Effect of propofol on myocardial ischemia-reperfusion injury through MAPK\/ERK pathway","volume":"23","author":"Yan","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"14","key":"10.1016\/j.jtcvs.2025.09.040_bib3","first-page":"6330","article-title":"Effect of propofol on myocardial ischemia\/reperfusion injury in rats through JAK\/STAT signaling pathway","volume":"23","author":"Chen","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.09.040_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40659-023-00428-3","article-title":"Propofol inhibits myocardial injury induced by microvesicles derived from hypoxia-reoxygenated endothelial cells via lncCCT4-2\/CCT4 signaling","volume":"56","author":"Zhang","year":"2023","journal-title":"Biol Res"},{"issue":"1-2","key":"10.1016\/j.jtcvs.2025.09.040_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2013.03.002","article-title":"Anti-inflammatory effects of propofol are mediated by apolipoprotein M in a hepatocyte nuclear factor-1alpha-dependent manner","volume":"533","author":"Ma","year":"2013","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10.1016\/j.jtcvs.2025.09.040_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/15353702-0323006-09","article-title":"Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass","volume":"230","author":"Lim","year":"2005","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.09.040_bib7","doi-asserted-by":"crossref","DOI":"10.2196\/resprot.3353","volume":"3","author":"Plummer","year":"2014","journal-title":"JMIR Res Protoc"},{"issue":"6","key":"10.1016\/j.jtcvs.2025.09.040_bib8","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jtcvs.2015.06.044","article-title":"Propofol cardioplegia: a single-center, placebo-controlled, randomized controlled trial","volume":"150","author":"Rogers","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.09.040_bib9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/02676591231157269","article-title":"Efficacy of propofol-supplemented cardioplegia on biomarkers of organ injury in patients having cardiac surgery using cardiopulmonary bypass: a protocol for a randomised controlled study (ProMPT2)","volume":"39","author":"Heys","year":"2024","journal-title":"Perfusion"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.09.040_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0003-4975(94)00843-V","article-title":"Intermittent antegrade warm blood cardioplegia","volume":"59","author":"Calafiore","year":"1995","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.09.040_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13063-024-08016-w","article-title":"Efficacy of propofol-supplemented cardioplegia on biomarkers of organ injury in patients having cardiac surgery using cardiopulmonary bypass: a statistical analysis plan for the ProMPT-2 randomised controlled trial","volume":"25","author":"Smartt","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.jtcvs.2025.09.040_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s43057-023-00103-z","article-title":"Cardioprotective effect of propofol in cardioplegia compared to systemic propofol in heart valves surgery; a randomized controlled trial","volume":"31","author":"Attia","year":"2023","journal-title":"Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.09.040_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4103\/0971-9784.166451","article-title":"Anti-inflammatory effects of propofol during cardiopulmonary bypass: a pilot study","volume":"18","author":"Samir","year":"2015","journal-title":"Ann Card Anaesth"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.09.040_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.jvca.2004.07.018","article-title":"The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting","volume":"18","author":"Corcoran","year":"2004","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtcvs.2025.09.040_bib15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/ALN.0000000000005655","article-title":"Gabapentin for pain management following major surgery: a placebo controlled, double blind, randomized clinical trial (the GAP study)","volume":"143","author":"Baos","year":"2025","journal-title":"Anesthesiology"},{"issue":"21","key":"10.1016\/j.jtcvs.2025.09.040_bib16","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/heartjnl-2024-324292","article-title":"Inequalities in access to and outcomes of cardiac surgery in England: retrospective analysis of Hospital Episode Statistics (2010-2019)","volume":"110","author":"Lai","year":"2024","journal-title":"Heart"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522325008517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522325008517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:30:28Z","timestamp":1780633828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522325008517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0022522325008517"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2025.09.040","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propofol-supplemented cardioplegia: A multicenter blinded 3-group randomized trial (Propofol for Myocardial Protection Trial 2: ProMPT2)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2025.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.","name":"copyright","label":"Copyright"}]}}